Please login to the form below
NICE wants more info on Genzyme's MS drug
UK health guidance body turns down Lemtrada in draft guidance
European Court may yet force AbbVie and InterMune to release data
Orders rethink on EMA's Humira and Esbriet injunction
Pfizer ups the ante on clinical transparency
Revamps access to data portal
Lilly depression drug fails late-stage trials
Will not pursue edivoxetine as an add-on treatment for depression
AZ said to be eyeing Forest takeover bid
Financial Times says pharma companies are in early negotiations
Smart Glasses: A new look for healthcare?
Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
Counting what counts
Measurement is the lifeblood of communications and brand investment in analytics is poised for steep growth
Technology-enhanced HIV service triumphs
Dean Street at Home initiative wins PMEA's digital/social award
Evoke Pharma adds to executive team
Appoints new chief medical officer and senior director of clinical operations
Personalised cancer support app wins Janssen prize
Px HealthcareCare takes first place, ahead of DrEd and Onco Drug Personalized Med
Featured jobs
- Global Brand Manager
- flexible salary + bonus + car allowance + benefits
- Brand Director - Highly Specialised Product - Global remit
- Highly Competitive Basic, Bonus + Benefits
- Commercial Manager
- Negotiable
- Regulatory Affairs Senior Manager, CMC - 12 month cotnract
- Competitive
Subscribe to our email news alerts
PMHub
eyeforpharma
eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay...
Latest intelligence
- Doctors’ disease knowledge: an insight into Latin America
- A lack of specialists outside major cities means many major illnesses go undiagnosed...
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
Quick links
